SNSF announces funding for EMPASTONE
In June 2025, the Swiss Nationanal Science Foundation (SNSF) announced that it would fund the EMPASTONE study. The study is being funded under the IICT programme (‘Investigator Initiated Clinical Trials’). Of a total of 47 applications, 6 (12%) were approved.